These results collectively indicate that PD‐L1 plays a critical role in promoting proliferation, invasion, and migration of prostate cancer cells that have become resistant to castration and suggest that targeting PD‐L1 could be a promising therapeutic strategy in managing CRPC. The gene discussed is CD274; the disease is prostate cancer.